课题基金 / 基金详情

Identification and analysis of the genes responsible for inherited neurodegenerative disorders

Identification and analysis of the genes responsible for inherited neurodegenerative disorders
鉴定和分析导致遗传性神经退行性疾病的基因
批准号:
09470041
负责人:
KAKIZUKA Akira
金额:
$8.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

KAKIZUKA Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A novel class of inherited human neurodegenerations is now known to be caused by expanded CAG repeats encoding polyglutamines. Polyglutamine-containing protein fragments have been shown to accumulate as aggregates in the nucleus and in the cytoplasm, and to induce cell death when expressed in cultured cells, leading to the proposal that polyglutamine aggregation is an important step in the pathogenesis. Supportingly, nuclear inclusions containing expanded polyglutamines have been identified in neurons from patient brains and in neurons from transgenic mouse models of this class of neural disorders.We analyzed the consequence of polyglutamine expression in PC12 neuronal cells. Activated SEK1 accumulated with nuclear but not cytoplasmic polyglutamine aggregations, which consequently triggers cell death. Cell death induced by polyglutamine expression was inhibited by a dominant-negative SEK1(DN-SEK1), but not by DN-SEKI tagged with a nuclear export signal. Steady state SEKI expression itself was enhanced by two to three fold. Nuclearly aggregated polyglutamines, which were identified in PML bodies, colocalized with not only activated SEKl but also activated c-Jun. We also observed that nuclear inclusion-positive neurons from Huntington disease brains expressed SEK 1.This study provides molecular links between neurodegeneration observed in polyglutamine diseases, cell death signalling kinase cascades, and nuclear subdomains related to cell death. We propose that the nuclear PML bodies containing polyglutamine aggregates activate the SEK1-JNK kinase cascade, resulting in transduction of a death signal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nakamoto,M.et al.: "A CAG/CGT expansion in the normal population." Nat.Genet.17. 385-386 (1997)
Nakamoto,M.et al.:“CAG/CGT 在正常人群中的扩展。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Imaizumi, M. et al.: "Mutations in the E-domain of RAR alpha portion of the PML/RAR alpha chimeric gene may confer clinical resistancc to all-trans retinoic acid in acute promyelocytic leukemia."BLOOD. 92. 374-382 (1998)
Imaizumi, M. 等人:“PML/RAR α 嵌合基因的 RAR α 部分 E 结构域中的突变可能会赋予急性早幼粒细胞白血病对全反式视黄酸的临床抵抗力。”BLOOD。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Segawa, T. et al.: "Prostate-specific amplification of expanded polyglutamine expression: A novel approach for cancer gene therapy"Cancer Res.. 58. 2282-2287 (1998)
Sekawa, T. 等人:“扩展聚谷氨酰胺表达的前列腺特异性扩增:癌症基因治疗的新方法”Cancer Res.. 58. 2282-2287 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Elucidation of novel functions of VCP, a major ATPase in the cell
    • 批准号:
      19H03435
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2019
    • 负责人:
      KAKIZUKA Akira
    • 依托单位:
    Analyses on novel functions of VCP, a major ATPase in the cell
    • 批准号:
      16H05151
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2016
    • 负责人:
      KAKIZUKA Akira
    • 依托单位:
    Analyses of the function and regulation of VCP, a major ATPase in the cells
    • 批准号:
      23249016
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.78万
    • 财政年份:
      2011
    • 负责人:
      KAKIZUKA Akira
    • 依托单位:
    Mechanisms for the regulation of growth and cell death in cancer cells
    • 批准号:
      17014043
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $27.78万
    • 财政年份:
      2005
    • 负责人:
      KAKIZUKA Akira
    • 依托单位:
    海外基金